Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Ottawa

$17,500.00

Technological Comparison of Short-Read and Long-Read Next-Generation Sequencing (NGS) Platforms for the Surveillance of the Gut Microbiome in Pediatric Inflammatory Bowel Disease (IBD)

FY 2021-22

Summary
The human gut microbiome represents the trillions of microbes and the environment within the gut. Recent research suggests that the gut microbiome is intimately linked with human health, and a dysregulated microbiome is associated with the development of chronic illnesses like inflammatory bowel disease (IBD). Thus, accurately assessing changes to the microbiome composition is paramount for understanding such diseases. To survey bacterial populations, which constitute an essential part of the gut microbiome, a fast and economical method called 16S rRNA (16S) sequencing is often used. Using DNA reading machines (sequencers), fingerprint DNA sequences present in all bacteria are analyzed. This fingerprint DNA is called the 16S gene and can be used to distinguish between different bacteria. However, standard DNA sequencers can only read sections of DNA long enough to span parts of the 16S gene (short-read), allowing distinction of most but not all bacteria. More sophisticated approaches to read all DNA in samples, that provide much more information, can be prohibitively expensive and not feasible for large sample sizes. Recently developed sequencers can read the entire 16S gene (long-read) at similar costs to short-read sequencers. My project will compare different short- and long-read sequencing technologies using pediatric IBD patient samples. Long-read 16S sequencing could potentially detect related but distinct bacteria that could not be detected using short-read technologies. This will enable more in-depth microbiome analysis without breaking the bank, leading to better understanding of the links between the gut microbiome and diseases like IBD. Ultimately, this brings us a step closer to improved therapeutics and outcomes for IBD patients.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
475260
Name
Shin Kenny K
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Technological Comparison of Short-Read and Long-Read Next-Generation Sequencing (NGS) Platforms for the Surveillance of the Gut Microbiome in Pediatric Inflammatory Bowel Disease (IBD)
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Shotgun Metagenomic Sequencing; 16s Rrna Sequencing; Bioinformatics; Gut Microbiome; Inflammatory Bowel Disease (Ibd); Long-Read Sequencing; Nanopore Sequencing; Personalized Medicine; Synthetic Long-Read (Slr)
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Shin, Kenny K
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~
Abstract
<html> <head> </head> <body> <span align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none"><font color="rgb(0, 0, 0)" face="Verdana, Arial, Helvetica, sans-serif" size="12.8px">The human gut microbiome represents the trillions of microbes and the environment within the gut. Recent research suggests that the gut microbiome is intimately linked with human health, and a dysregulated microbiome is associated with the development of chronic illnesses like inflammatory bowel disease (IBD). Thus, accurately assessing changes to the microbiome composition is paramount for understanding such diseases. To survey bacterial populations, which constitute an essential part of the gut microbiome, a fast and economical method called 16S rRNA (16S) sequencing is often used. Using DNA reading machines (sequencers),</font></span><font color="rgb(0, 0, 0)" face="Verdana, Arial, Helvetica, sans-serif" size="12.8px"><span>&#160;</span><em align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)">fingerprint</em><span>&#160;</span><span align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none">DNA sequences present in all bacteria are analyzed. This</span><span>&#160;</span><em align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)">fingerprint</em><span>&#160;</span><span align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none">DNA is called the</span><span>&#160;</span><em align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)">16S gene</em><span>&#160;</span><span align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none">and can be used to distinguish between different bacteria. However, standard DNA sequencers can only read sections of DNA long enough to span parts of the 16S gene (short-read), allowing distinction of</span><span>&#160;</span><em align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)">most<span>&#160;</span></em><span align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none">but not</span><span>&#160;</span><em align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)">all</em><span>&#160;</span><span align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none">bacteria. More sophisticated approaches to read all DNA in samples, that provide much more information, can be prohibitively expensive and not feasible for large sample sizes. Recently developed sequencers can read the entire 16S gene (long-read) at similar costs to short-read sequencers. My project will compare different short- and long-read sequencing technologies using pediatric IBD patient samples.</span><span>&#160;</span><em align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)">Long-read</em><span>&#160;</span><span align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none">16S sequencing could potentially detect related but distinct bacteria that could not be detected using</span><span>&#160;</span><em align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)">short-read</em><span>&#160;</span><span align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none">technologies. This will enable more in-depth microbiome analysis without breaking the bank, leading to better understanding of the links between the gut microbiome and diseases like IBD. Ultimately, this brings us a step closer to improved therapeutics and outcomes for IBD patients.</span></font> </body> </html>